Subsidiaries and holdings
- PHARMA TECHNOLOGY99.96%
PHARMA FLEX
ActiveSummary
PHARMA FLEX has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10.5m and a net result of €4.3m. Equity has been shrinking by about 3.4% per year since 2018. Its solvency ranks better than 88% of 384 sector peers (NACE 28, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 04-04-2008 Normal situation
- Activity
- Manufacture of machinery and equipment not elsewhere classified NACE 28990and 2 others
- Joint committee
- 200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
- Establishment unit
- 2.172.568.782 1402 Nivelles, since 11-04-2008
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Board and ownership
Board
- AdFines SrlDirector · since 09-02-2024
- ADFINITIS SRLDirector · since 09-02-2024 · permanent representative DOLLINGER Martial
- NextGen Invest SrlDirector · since 09-02-2024
- Auditor
- RdB SRL
Shareholders
- AdFinitis55%30-06-2025 annual accounts of AdFinitis
- NextGen Invest32%2025 annual accounts of NextGen Invest
- AdFines13%2025 annual accounts of AdFines
- Holdings
- Shares in 4 companies including PHARMA TECHNOLOGY - PHARMA FLEX GMBH and PHARMA TECHNOLOGY ASIA PACIFIC LTD
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
Annual accounts 2025
- Turnover
- €2.1m
- ▲ 10.4%
- Profit
- €4.3m
- ▼ 41.4%
- Equity
- €10.5m
- ▲ 7.9%
- Total assets
- €14.3m
- ▲ 3.3%
- Employees on 31-12-2025
- 4
- =
Score breakdownlowers riskFounded in 2008Size: turnover €2.1m, 3.8 FTE, total assets €14.3mFigures for financial year 2025 (filed on 27-03-2026)Equity €10.5m (73.3% of total assets)Show the evidence
Checked score
Score 2025
95
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 63% of micro companies in machinery and equipment (NACE 28)
Financial strength · tick: 2024
Strong
Solvency
98+3
equity 73.3% of total assets
Liquidity
53+5
short-term debt 26.2% · cash 10.6%
Profitability
78+29
return on assets 30.3%
Bankruptcy probability within 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025highest value
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026lowest value
05-2026: 0.1%● unchanged vs 04-2026lowest value
06-2026: 0.1%● unchanged vs 05-2026lowest value
07-2026: 0.1%● unchanged vs 06-2026lowest value
08-2026: 0.1%● unchanged vs 07-2026lowest value
09-2026: 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026lowest value
11-2026: 0.1%● unchanged vs 10-2026lowest value
Credit of up to €210,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.84 (0.66 in 2024), below 1. Short-term debt is 26.2% and cash 10.6% of total assets. 26.7% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 28, micro). It does better than 77% of them on solvency, 50% on liquidity, 63% on profitability and 62% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskneutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €10.5m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
126 days early
2024
107 days early
2023
42 days early
2022
32 days early
2021
3 days early
2020
3 days early
2019
21 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 48 days before the deadline. In the sector (NACE 28), the median for financial year 2024 was 11 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 June (4 of the last 5 accounts filed within 66 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
Key points
- Positive: Higher net result than 93% of companies in machinery and equipmentsector median €150,798 · 384 companies €4.3m View
- Caution: Result fell in 2025from €7.4m to €4.3m ▼ 41.4% View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Positive: 8 profitable years in a rowprofit 2025: €4.3m 8 years View
Recent changes
- · Gazette deed Reappointment: Renaud de Borman,Réviseur d'entreprises-Bedrijfsrevisor (statutory auditor)
- · Gazette deed Resignation: DOLLINGER Martial (director)Appointment: ADFINITIS SRL (director)
- · Gazette deed Appointments: DOLLINGER Martial Arthur Charles Benoit (statutory director) and BECKER Claire Andrée Ingrid (statutory director)
Companies linked to PHARMA FLEX
Comparable companies
These companies have the same main activity as PHARMA FLEX: manufacture of machinery and equipment not elsewhere classified (NACE 28990). They are comparable in size and age: total assets between €2.6m and €8.2m, founded between 1994 and 2012.
| Company | Total assets | Turnover |
|---|---|---|
| PHARMA FLEX Nivelles | €14.3m | €2.1m |
| PROCEPT Zele | €8.2m | - |
| NAESSENS HYDRAULICS Oosterzele | €5.4m | - |
| VENTILEC Lokeren | €6.2m | - |
| ARENA COMET Lokeren | €3.1m | - |
| VANDEMOORTELE Lendelede | €2.6m | - |
| 'T KLUIZEBOS Oostende | €3.2m | - |
Key facts about PHARMA FLEX
- What is the company number of PHARMA FLEX?
- The company number of PHARMA FLEX is 0897.187.147. The VAT number is the same number with BE in front: BE 0897.187.147.
- Where is PHARMA FLEX based?
- The registered office is at Rue Graham Bell 8, 1402 Nivelles.Company details
- What does PHARMA FLEX do?
- According to the KBO register, the main activity is manufacture of machinery and equipment not elsewhere classified (NACE 28990).
- What is the legal form of PHARMA FLEX?
- The legal form of PHARMA FLEX is Public limited company (NV).
- When was PHARMA FLEX founded?
- PHARMA FLEX was founded on 04-04-2008.
- Is PHARMA FLEX still active?
- Yes, PHARMA FLEX is an active enterprise in the KBO register.
- How many employees does PHARMA FLEX have?
- PHARMA FLEX had an average of 3.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does PHARMA FLEX fall under?
- In its 2025 annual accounts, PHARMA FLEX states joint committee 200 (Aanvullend Paritair Comité voor de bedienden).
- What is the turnover of PHARMA FLEX?
- The turnover of PHARMA FLEX was €2.1m in financial year 2025, according to the filed annual accounts.
- Is PHARMA FLEX profitable?
- In financial year 2025, PHARMA FLEX made a profit of €4.3m.
- Where can I find the annual accounts of PHARMA FLEX?
- PHARMA FLEX filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMA FLEX due?
- PHARMA FLEX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.